At 9:00 am on January 17, 2016, the " Sunlight Pharmaceutical 2015 annual year-end Summary and commendation Conference" was successfully held in the Sunshine Auditorium, and the conference was presided over by the executive deputy General manager of Sunlight Pharmaceutical.

On the rostrum of this staff meeting are leaders above the minister of Sunlight Pharmaceutical, including professors, doctors and postdocs who have returned from studying in Europe and the United States. Graduated from Xi 'an Jiaotong University Doctor of Law, Chinese Academy of Sciences Shanghai Institute of Materia Medica postdoctoral, Chinese Academy of Sciences Guangzhou Institute of Biomedicine and Health doctor, and invited Tsinghua University senior engineer General Luan attended the meeting.

The executive deputy general manager of Sunlight Pharmaceutical made the "2015 annual Work Summary Report" from eight aspects. The report points out that the company always focuses on the development concept of "everything can be changed, only the company's goal cannot be changed" and the development idea of "two learning, two relying, dual-use" (two learning: learning dedication, learning domestic and foreign project application experience, two relying on: market, technology, dual-use: wisdom, platform); Vigorously promote the company's leading cadres to practice the "five transcendence, eight clear" normalization and long-term. The company will continue to expand the exchanges and cooperation with the global top 500 enterprises, the exchanges and cooperation with China's top 100 pharmaceutical enterprises and the exchanges and cooperation with China's top 10 military enterprises, so as to achieve the combination of strong enterprises and win-win cooperation; World affairs, done in fine, into words, with Hu as the core of the leadership team from the beginning of the "one check, two core, three adjustment" specific work requirements, grasp the key and key, play out a series of "combined fists" (a check: check the problems existing in the work, two core: the previous arrangement of the work has not been completed, three tones: Make reasonable adjustments to unreasonable places), be serious and down-to-earth to do all the work.

The chief engineer of Sunshine Pharmaceutical read out the "Decision on recognizing 2015 advanced workers" : There were 27 advanced workers in 2015. The election of advanced workers is the Sunshine company adhering to the principle of fair, just and open voting election; "Respect for knowledge, respect for talent" is our Sunlight company's excellent cultural tradition, but also a part of the core culture.

Sunlight Pharmaceutical marketing deputy general manager on behalf of the company sales report: In the domestic and foreign economic weakness, increasingly fierce competition situation, Sunlight company in 2015 to create a new sales record. In 2015, we received 112 visits from domestic and foreign customers, participated in foreign exhibitions (USA, Spain, Russia, Japan, South Korea, Switzerland), visited customers 19 times, more than 200 people. In the two major business areas of medicine and new material monomer, we have established stable business relationships with many of the world's top 500 enterprises, and established long-term strategic cooperative relations with many domestic top 100 pharmaceutical enterprises, laying a solid foundation for Sunlight to become a "hundred-year pharmaceutical enterprise".

In recent years, Sunlight Pharmaceutical has continuously increased the introduction of talents. At present, the company has 6 doctors, 19 masters, and 139 college students from 98 domestic and foreign universities and scientific research institutions, accounting for 41.8% of the total number of enterprises. At the conference, two doctors from the R&D center made a technical report on behalf of the R&D center; In 2016, we will continue to increase the introduction of outstanding talents in medicine and new materials, and strengthen the technical force for the development of the company's pharmaceutical and new materials industry. General manager of Sunlight Pharmaceutical made the "Sunshine Pharmaceutical 2016 work Outlook" from eight aspects. He said: in 2016, the Sunlight Pharmaceutical preparation project to further improve the construction of related supporting facilities, at the same time, the second phase of the project will also be carried out; The installation and supporting engineering construction of the workshop of the joint venture project in Spain have been basically in place; The drawing of the new project of the material company has been completed, and the preliminary design scheme has been released; Yancheng Company will add 100 acres of land for the construction of a new API workshop; In 2016, Sunlight will also set up academicians and doctoral workstations, introduce more than 2 doctors and postdocs, and more than 10 masters; In the field of biomedicine, we develop three new drugs for the treatment of diabetes and cardiovascular diseases. In the field of new materials, we develop new high-performance materials for military and civilian products. At the same time, it will also apply for national major basic research fund projects, and will complete the acceptance of major scientific and technological achievements transformation projects in Jiangsu Province; In 2016, the company will maintain a 20% growth rate on the basis of 2015, and strive to complete 550 million yuan of sales and 80 million yuan of profits and taxes.